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Ventilator-associated pneumonia (VAP) is a frequent hospital-acquired 
infection occurring in mechanically ventilated patients, with a mortality of 
20-70%. These infections are often caused by mixed populations of 
bacteria and yeast, which combined with the indiscriminate use of 
antimicrobials leads to ineffective treatment and contributes to the 
emergence of multidrug resistant pathogens.The understanding of 
antimicrobial resistance and the development of new antimicrobial 
strategies is attracting considerable research interest. In this scope, this 
work aimed to characterize single and dual species biofilms of 
Pseudomonas aeruginosa and Candida albicans, common in VAP 
infection, and to assess the effect of combinational antimicrobial therapy 
using amphotericin B (AmB) and polymyxin B (PolyB).Phenotypic 
analysis of single species biofilms revealed C. albicans biomass reduction 
after 48 h. Dual-species biofilms were dominated by P. aeruginosa. The 
activity of isolated antimicrobials was evaluated against planktonic 
cultures with AmB being most effective against C. albicans and PolyB 
against P. aeruginosa. Mixed planktonic cultures required equal or higher 
concentrations. In biofilms, only PolyB reduced the microbial population, 
affecting P. aeruginosa in both single and dual-species biofilms, but only 
at the highest doses. The antimicrobial combinations had a synergistic 
effect in dual-species planktonic and biofilm cultures, but biofilms were 
able to regrow.To conclude, combination of antimicrobials shows 
promising results in the treatment of VAP involving mixed populations, but 
further optimization of doses and timing of administration are required to 
avoid reinfection. 
